Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blind

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 3, 2023
A call to action: Health-system pharmacists must stand up to meet the growing demand for cellular-based therapiesJill E Blind, Diana N Nowicki, Kimberly McConnell, et al.
Thyroid : Official Journal of the American Thyroid Association|January 1, 1992
Chromogranin A as tumor marker in medullary thyroid carcinomaE Blind, H Schmidt-Gayk, H P Sinn, et al.
The Journal of Endocrinology|July 6, 2002
Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor familyI A Hansen, O Jakob, S Wortmann, et al.
Bone|February 22, 2001
Changing serine-485 to alanine in the opossum parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of phospholipase C in a stably transfected human kidney cell line: a useful model for PTH-analog screening?M R John, J Bösel, S Breit, et al.
Deutsche Medizinische Wochenschrift (1946)|November 12, 1998
[Changes in thyroxine-binding globulin: pitfalls in thyroid function diagnosis]M R John, E Blind, A Grauer, et al.
Journal of Endocrinological Investigation|February 1, 1992
Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinomaE Blind, F Raue, T Klaiber, et al.
Bone|April 1, 1996
Glucocorticoids decrease the production of parathyroid hormone-related protein in vitro but not in vivo in the Walker carcinosarcoma 256 rat modelT Schilling, M Pecherstorfer, E Blind, et al.
The British Journal of Surgery|February 1, 1990
Intact parathyroid hormone in primary hyperparathyroidismD Flentje, H Schmidt-Gayk, S Fischer, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1994
Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patientsM Pecherstorfer, T Schilling, E Blind, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1988
Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assayE Blind, H Schmidt-Gayk, S Scharla, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 3, 2023
A call to action: Health-system pharmacists must stand up to meet the growing demand for cellular-based therapiesJill E Blind, Diana N Nowicki, Kimberly McConnell, et al.
Thyroid : Official Journal of the American Thyroid Association|January 1, 1992
Chromogranin A as tumor marker in medullary thyroid carcinomaE Blind, H Schmidt-Gayk, H P Sinn, et al.
The Journal of Endocrinology|July 6, 2002
Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor familyI A Hansen, O Jakob, S Wortmann, et al.
Bone|February 22, 2001
Changing serine-485 to alanine in the opossum parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of phospholipase C in a stably transfected human kidney cell line: a useful model for PTH-analog screening?M R John, J Bösel, S Breit, et al.
Deutsche Medizinische Wochenschrift (1946)|November 12, 1998
[Changes in thyroxine-binding globulin: pitfalls in thyroid function diagnosis]M R John, E Blind, A Grauer, et al.
Journal of Endocrinological Investigation|February 1, 1992
Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinomaE Blind, F Raue, T Klaiber, et al.
Bone|April 1, 1996
Glucocorticoids decrease the production of parathyroid hormone-related protein in vitro but not in vivo in the Walker carcinosarcoma 256 rat modelT Schilling, M Pecherstorfer, E Blind, et al.
The British Journal of Surgery|February 1, 1990
Intact parathyroid hormone in primary hyperparathyroidismD Flentje, H Schmidt-Gayk, S Fischer, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1994
Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patientsM Pecherstorfer, T Schilling, E Blind, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1988
Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assayE Blind, H Schmidt-Gayk, S Scharla, et al.
Pageof 5